fbpx

Sputnik V recommended for emergency use

  • IASbaba
  • April 13, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

Sputnik V recommended for emergency use

Part of: GS Prelims and GS – II – Health 

In news

  • Russia’s COVID-19 vaccine — Sputnik V — has been recommended for emergency use authorisation in India following a meeting of the Subject Expert Committee (SEC).

Key takeaways 

  • If approved by the Drug Controller General of India (DCGI), Sputnik V would be the third vaccine to be made available in India after the Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.
  • Sputnik V is developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology
  • It claims to be one of the three vaccines in the world with efficacy of over 90%.
  • The vaccine supplies for the global market will be produced by the Russian Direct Investment Fund (RDIF) international partners in India, Brazil, China, South Korea and other countries.

For a dedicated peer group, Motivation & Quick updates, Join our official telegram channel – https://t.me/IASbabaOfficialAccount

Search now.....